Follow
Nephrocheck
The NephroCheck® Test assesses Acute Kidney Injury (AKI) risk in hospitalized patients. While developing the produce, hundreds of biomarkers were screened and two (TIMP-2 and IGFBP-7) were identified to significantly aid doctors assessing AKI risk. NephroCheck® Testing identifies patietns at high risk for AKI allowing for early intervention and improved outcomes.
